Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition capable of preventing African swine fever, and injection and application thereof

A technology of African swine fever and a composition, applied in the field of animal husbandry, can solve problems such as non-prevention of African swine fever, and achieve the effects of improving ketone body quality, inhibiting fat oxidation, and being widely used

Pending Publication Date: 2019-12-20
成都兴旺动物药业有限公司 +1
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no effective drug to prevent African swine fever, and an effective drug to prevent African swine fever is urgently needed to solve the major problems encountered in pig breeding

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition capable of preventing African swine fever, and injection and application thereof
  • Pharmaceutical composition capable of preventing African swine fever, and injection and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] A pharmaceutical composition for preventing African swine fever, the pharmaceutical composition comprising the following raw materials in parts by weight: 400 parts of gypsum, 100 parts of Anemarrhena, 100 parts of bamboo leaves, 60 parts of raw land, 60 parts of Scrophulariaceae, 50 parts of Coptidis, Scutellaria baicalensis 50 parts, gardenia 50 parts. Extract the above raw materials according to conventional methods (such as direct water extraction or alcohol extraction), and prepare the extracts into injections according to conventional methods, and each 1ml of injection contains 3.0g equivalent to the original medicinal material.

Embodiment 2

[0042] A pharmaceutical composition for preventing African swine fever, the pharmaceutical composition comprising the following raw materials in parts by weight: 10 parts of gypsum, 5 parts of Anemarrhena, 5 parts of light bamboo leaves, 5 parts of rehmannia root, 5 parts of Scrophulariaceae, and 5 parts of Coptis chinensis , 5 parts of Scutellaria, 5 parts of Gardenia. Extract the above raw materials according to conventional methods (such as direct water extraction or alcohol extraction), and prepare the extracts into injections according to conventional methods, and each 1ml of injection contains 2g of raw medicinal materials.

Embodiment 3

[0044] A pharmaceutical composition for preventing African swine fever, the pharmaceutical composition comprising the following raw materials in parts by weight: 1000 parts of gypsum, 200 parts of Zhimu, 200 parts of light bamboo leaves, 200 parts of rehmannia glutinosa, 200 parts of Scrophulariaceae, and 200 parts of Coptis chinensis , Scutellaria baicalensis 200 parts, gardenia 200 parts. Extract the above raw materials according to conventional methods (such as direct water extraction or alcohol extraction), and prepare the extracts into injections according to conventional methods, and each 1ml of injection contains 4g of raw medicinal materials.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition capable of preventing African swine fever as well as injection and application thereof. The pharmaceutical composition capable of preventing African swine fever is prepared from the following raw materials in parts by weight: 10-1000 parts of gypsum, 5-200 parts of common anemarrhena rhizome, 5-200 parts of lophatherum herb, 5-200 parts of raw radix rehmanniae, 5-200 parts of radix scrophulariae, 5-200 parts of rhizoma coptidis, 5-200 parts of baical skullcap roots, and 5-200 parts of fructus gardeniae. The raw materials are extracted by water or alcohol so as to obtain a drug extract; the drug extract is dissolved in water; and then, benzenemethanol, tween-80 and activated carbon injection are added, and filtration is carried out so asto obtain the pharmaceutical composition capable of preventing African swine fever. The pharmaceutical composition disclosed by the invention has preventive effects on a plurality of viral infectionssuch as African swine fever virus infection and the like; and moreover, the pharmaceutical composition is free of antibiotics and drug residues. In addition, the pharmaceutical composition capable ofpreventing African swine fever has significant preventive effects on African swine fever virus that the effective rate is about 80%.

Description

technical field [0001] The invention belongs to the technical field of animal husbandry, and in particular relates to a pharmaceutical composition for preventing African swine fever, an injection thereof and application thereof. Background technique [0002] African swine fever, originated in Africa, double-stranded DNA enveloped virus, is caused by African swine fever virus family, African swine fever virus, African swine fever virus (ASFV), an acute disease of pigs and wild boars , Potent, highly contagious, fatal infectious disease, pigs and wild boars are the only natural hosts of the virus. There is no seasonality in the incidence, and the transmission route is contact transmission and insect vector transmission. First identified in Kenya in 1921, it was introduced to Europe in 1957, the Americas in 1971, Russia in 2007, Ukraine in 2012, and Belarus in 2013. It was introduced to Poland, Lithuania, Latvia and Estonia in 2014, Moldova in 2016, Czech Republic and Romania...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61K9/08A61P31/20A61K33/06
CPCA61K9/0019A61K9/08A61K33/06A61K36/539A61K36/718A61K36/744A61K36/804A61K36/808A61K36/8964A61K36/899A61K47/10A61K47/26A61P31/20A61K2300/00
Inventor 苟中海赵琳唐海
Owner 成都兴旺动物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com